ijmegen Exercise Study: the role of physical activity on the prevention of cardiovascular diseases
Recruiting
- Conditions
- cardiovascular diseasescancer1008220610003216
- Registration Number
- NL-OMON36083
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 24500
Inclusion Criteria
- older than 18 years
- participant of the Nijmegen Four Days Marches 2011
- for the subgroup with additional measurements subjects must be younger than 80 years
Exclusion Criteria
There are no exclusion criteria for participation in this oberservational cohort study.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary study parameter is the development of cardiovascular and/or chronic<br /><br>diseases.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Blood determinations (glucose, lipid profile)<br /><br>Anthropometric data<br /><br>Blood pressure<br /><br>Maximal handgrip exercise<br /><br>Walking characteristics</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does physical activity modulate to prevent cardiovascular diseases and cancer in NL-OMON36083?
How does structured physical activity compare to statin therapy in preventing cardiovascular diseases among high-risk individuals in the Nijmegen Exercise Study?
Which biomarkers correlate with cardiovascular risk reduction in NL-OMON36083 participants undergoing physical activity interventions?
What adverse events are associated with high-intensity physical activity in NL-OMON36083 and how are they managed?
How does physical activity in NL-OMON36083 synergize with dietary interventions to reduce cancer and cardiovascular disease risk?